Trials / Completed
CompletedNCT02241564
Malignancies in Transplanted Patients
Follow-up of Malignancies in Transplanted Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the project is to improve the overall treatment and outcome of renal, pancreas or liver transplanted patients who have encountered a malignancy by a structured treatment program for diagnosis and treatment of the malignancy, optimization of the immunosuppressive treatment, follow-up and evaluation of the program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Referral to a multidisciplinary expert panel at the Uppsala University Hospital after tumor detection | |
| DRUG | Switch from calcineurin inhibitor to an mTOR inhibitor |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2014-09-16
- Last updated
- 2017-10-26
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02241564. Inclusion in this directory is not an endorsement.